EUVIMEDEUVIMED entdecken
Scoping Review

Ethical Challenges and Considerations in Decentralized Clinical Trials (DCTs): Insights from a Scoping Review

Lijia Han, Kai Hong Ooi, Krisna Veni Balakrishnan, Chia Wei Phan

Therapeutic Innovation & Regulatory Science · 2026-05 · 60 (3) · 904-924

DOI: 10.1007/s43441-026-00949-5 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Therapeutic Innovation & Regulatory Science, online erschienen am 10.03.2026. Verfasst von Lijia Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Humanities and Ethics Unit, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Clinical Trials as Topic. Die Arbeit nennt 51 Literaturangaben. Gefördert von: FIC NIH HHS, Fogarty International Center of the United States, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Decentralized clinical trials (DCTs) leverage digital health technologies to conduct trials outside traditional settings, offering numerous benefits such as increased participant diversity and breaking down geographic and transportation barriers. However, they also present significant ethical challenges. Current regulatory and ethical frameworks are not fully equipped to address these issues, highlighting a critical gap in effective governance and oversight of DCTs. This scoping review aims to systematically identify and synthesise the ethical challenges reported in the literature and to outline recommendations that can inform future guidance and practice. METHODS: This scoping review followed Arksey and O'Malley's framework. We searched PubMed, Web of Science, and SCOPUS for peer-reviewed articles in English and applied predefined inclusion and exclusion criteria to guide study selection. RESULTS: The initial search yielded 757 documents. After applying inclusion and exclusion criteria and conducting a rigorous two-stage screening process, 32 articles were selected for detailed analysis. These articles identified six main areas of ethical challenges: electronic informed consent, equity and access, privacy and confidentiality, participant safety and welfare, scientific validity, and ethical and regulatory oversight. CONCLUSIONS: This review underscores the necessity for clear guidelines, enhanced digital literacy, robust data protection measures, and comprehensive regulatory frameworks to address the ethical challenges of DCTs. By synthesizing existing literature, this paper provides actionable recommendations, such as simplifying consent processes and improving technical support, and identifies areas for future research to ensure DCTs are conducted ethically and effectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicHumansInformed ConsentConfidentialityDigital Health

Stichwörter der Autor:innen

ChallengesDCTsDecentralized clinical trialsDigital health technologiesEthicsRecommendations

Autor:innen und Institutionen

  • Medical Humanities and Ethics Unit, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
  • Bioscience and Biomedical Engineering Thrust, System Hub, The Hong Kong University of Science and Technology, Nansha District, Guangzhou, China.
  • Clinical Investigation Centre (CIC), 5th Floor, East Tower, University Malaya Medical Centre (UMMC), 59100, Lembah Pantai, Kuala Lumpur, Malaysia.
  • Clinical Investigation Centre (CIC), 5th Floor, East Tower, University Malaya Medical Centre (UMMC), 59100, Lembah Pantai, Kuala Lumpur, Malaysia. phancw@um.edu.my.
  • Department of Pharmaceutical Life Sciences, Faculty of Pharmacy, Universiti Malaya, 50603, Kuala Lumpur, Malaysia. phancw@um.edu.my.

Förderung

  • FIC NIH HHS
  • Fogarty International Center of the United States, National Institutes of Health

Zitieren

APA

Han, L., Ooi, K. H., Balakrishnan, K. V., & Phan, C. W. (2026). Ethical Challenges and Considerations in Decentralized Clinical Trials (DCTs): Insights from a Scoping Review. Therapeutic Innovation & Regulatory Science, 60(3), 904-924. https://doi.org/10.1007/s43441-026-00949-5

Vancouver

Han L, Ooi KH, Balakrishnan KV, Phan CW. Ethical Challenges and Considerations in Decentralized Clinical Trials (DCTs): Insights from a Scoping Review. Therapeutic Innovation & Regulatory Science. 2026;60(3):904-924. doi:10.1007/s43441-026-00949-5

BibTeX
@article{Han2026,
  author = {Han, Lijia and Ooi, Kai Hong and Balakrishnan, Krisna Veni and Phan, Chia Wei},
  title = {Ethical Challenges and Considerations in Decentralized Clinical Trials (DCTs): Insights from a Scoping Review},
  journal = {Therapeutic Innovation & Regulatory Science},
  year = {2026},
  volume = {60},
  number = {3},
  pages = {904--924},
  doi = {10.1007/s43441-026-00949-5}
}
Kostenlos starten →